244
Views
4
CrossRef citations to date
0
Altmetric
Review

A decade of nutraceutical patents: where are we now in 2018?

ORCID Icon, ORCID Icon & ORCID Icon
Pages 875-882 | Received 11 Oct 2018, Accepted 21 Nov 2018, Published online: 29 Nov 2018

References

  • DeFelice SL. FIM rationale and proposed guidelines for the nutraceutical research & education act-NREA. Foundation for Innovation in Medicine. 2002. [cited 2018 Oct 10]. Available from: http://www.fimdefelice.org/archives/arc.researchact.html
  • Kalra EK. Nutraceutical definition and introduction. AAPS PharmSci. 2003;5:27–28.
  • Borchers AT, Keen CL, Gershwin ME. The basis of structure function claims of nutraceuticals. Clin Rev Allergy Immunol. 2016;51:370–382.
  • Santini A, Cammarata SM, Capone A, et al. Nutraceuticals: opening the debate for a regulatory framework. Br J Clin Pharmacol. 2018;84:659–672.
  • Dey P, Jain N, Nagaich U. Nutraceuticals: an overview of regulations. Int J Pharm Life Sci. 2018;9:5762–5766.
  • Rao KS. Safety Assessment of Nutraceuticals. BEMS Rep. 2017;3:70–72.
  • Micol Molina V. Nutraceuticals molecular targets (I) The divorce between legislation, market and science. Agro Food Ind Hi-Tech. 2017;28:52–53.
  • Yeung AWK, Mocan A, Atanasov AG. Let food be thy medicine and medicine be thy food: a bibliometric analysis of the most cited papers focusing on nutraceuticals and functional foods. Food Chem. 2018;269:455–465.
  • Das L, Bhaumik E, Raychaudhuri U, et al. Role of nutraceuticals in human health. J Food Sci Technol. 2012;49:173–183.
  • Nur Syazana U, Rani M, Dzulkhairi M, et al. A review of prophetic nutraceutical foods: issues and challenges. Adv Sci Lett. 2016;22:2147–2151.
  • Santini A, Tenore GC, Novellino E. Nutraceuticals: a paradigm of proactive medicine. Eur J Pharm Sci. 2017;96:53–61.
  • Nutraceuticals market analysis by product (dietary supplements, functional food, functional beverage), by region (North America, Asia Pacific, Europe, CSA, MEA), and segment forecasts, 2018-2025. [cited 2018 Oct 10]. Available from: https://www.grandviewresearch.com/industry-analysis/nutraceuticals-market
  • Unites States Food and Drug Administration. [cited 2018 Oct 10]. Available from: https://www.fda.gov/food/dietarysupplements
  • Abdel-Daim M, Abushouk AI, Reggi R, et al. Association of antioxidant nutraceuticals and acetaminophen (paracetamol): friend or foe? J Food Drug Anal. 2018;26:S78–S87.
  • Ronis MJJ, Pedersen KB, James W. Adverse effects of nutraceuticals and dietary supplements. Ann Rev of Pharmacol Toxicol. 2018;58:583–601.
  • Assadpour E, Jafari SM. A systematic review on nanoencapsulation of food bioactive ingredients and nutraceuticals by various nanocarriers. Crit Rev Food Sci Nut. 2018. DOI:10.1080/10408398.2018.1484687
  • Augustin MA, Sanguansri L. Challenges and solutions to incorporation of nutraceuticals in foods. Annu Rev Food Sci Technol. 2014;6(1):463–477.
  • Di Cerbo A, Palmieri B, Aponte M, et al. Mechanisms and therapeutic effectiveness of lactobacilli. J Clin Pathol. 2016;69:187–203.
  • Blaiotta G, Murru N, Di Cerbo A, et al. Production of probiotic bovine salami using Lactobacillus plantarum 299v as adjunct. J Sci Food Agric. 2018;98:2285–2294.
  • Romano A, Blaiotta G, Di Cerbo A, et al. Spray-dried chestnut extract containing Lactobacillus rhamnosus cells as novel ingredient for a probiotic chestnut mousse. J Appl Microbiol. 2014;116:1632–1641.
  • Blaiotta G, Murro N, Di Cerbo A, et al. Commercially standardized process for probiotic Italico cheese production. LWT Food Sci Technol. 2017;79:601–608.
  • Di Cerbo A, Pezzuto F, Palmieri L, et al. Clinical use of probiotic formulations for management of end stage renal disease: an update. Int Urol Nephrol. 2013;45:1569–1576.
  • Yamakoshi J, Kataoka SH, Koga T, et al. Proanthocyanidin-rich extract from grape seeds attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits. Atherosclerosis. 1999;142:139–149.
  • German JB, Walzem RL. The health benefits of wine. Annu Rev Nutr. 2000;20:561–593.
  • Velayutham P, Babu A, Liu D. Green tea catechins and cardiovascular health: an update. Curr Med Chem. 2008;15:1840–1850.
  • Sirtori CR, Galli C. Fatty acids and the Omega 3. Biomed Pharmacother. 2002;56:397–406.
  • Allen RM, Vickers KC. Coenzyme Q10 increases cholesterol efflux and inhibits atherosclerosis through microRNAs. Arterioscler Thromb Vasc Biol. 2014;34(9):1795–1797.
  • Clifton PM, Noakes M, Sullivan D, et al. Cholesterol-lowering effects of plant sterol esters differ in milk, yoghurt, bread and cereal. Eur J Clin Nutr. 2004;58:503–509.
  • Kris-Etherton PM, Hecker KD, Bonanome A, et al. Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am J Med. 2002;113:71–88.
  • Derosa G, Limas CP, Macías PC, et al. Dietary and nutraceutical approach to type 2 diabetes. Arch Med Sci. 2014;10:336–344.
  • Coleman MD, Eason RC, Bailey CJ. The therapeutic use of lipoic acid in diabetes: a current perspective. Environ Toxicol Pharmacol. 2001;10:167–172.
  • Baljit S. Psyllium as therapeutic and drug delivery agent. Int J Pharm. 2007;334:1–14.
  • Rafehi H, Ververis K, Karagiannis TC. Controversies surrounding the clinical potential of cinnamon for the management of diabetes. Diabetes Obesity Metab. 2012;14:493–499.
  • Ghosh D, Konishi T. Anthocyanins and anthocyanin-rich extracts: role in diabetes and eye function. Asia Pac J Clin Nutr. 2007;16(2):200–208.
  • Parasuram RR, Rawat BM, Thangvel SK. Nutraceuticals: an area of tremendous scope. Int J Res Ayurveda Pharm. 2011;2:410–415.
  • Yin J, Xing H YJ. Efficacy of Berberine in patients with type 2 diabetes. Metabolism. 2008;57:712–717.
  • Reyes GC, Koda RT, Lein EJ. Glucosamine and Chondroitin sulfates in the treatment of osteoarthritis: a survey. Prog Drug Res. 2000;55:81–103.
  • Daneault A, Prawitt J, Fabien Soulé V, et al. Biological effect of hydrolyzed collagen on bone metabolism. Crit Rev Food Sci Nutr. 2017;57:1922–1937.
  • Kasbia GS. Functional foods and nutraceuticals in the management of obesity. Nutr Food Sci. 2005;35:344–351.
  • Pekala J, Patkowska-Sokoła B, Bodkowski R, et al. L-carnitine-metabolic functions and meaning in humans life. Curr Drug Metab. 2011;12:667–678.
  • Krawinkel MB, Ludwig C, Swai ME, et al. Bitter gourd reduces elevated fasting plasma glucose levels in an intervention study among prediabetics in Tanzania. J Ethnopharmacol. 2018;216:1–7.
  • Sunita P, Pattanayak SP. Phytoestrogens in postmenopausal indications: a theoretical perspective. Pharmacogn Rev. 2011;5(9):41–44.
  • Barnes J, Anderson LA, Gibbons S, et al. Echinacea species (Echinacea angustifolia (DC.). Hell Echinacea pallida (Nutt.) Nutt Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties. J Pharm Pharmacol. 2005;57:929–954.
  • Hayashi K, Narutaki K, Nagaoka Y, et al. Therapeutic effect of arctiin and arctigenin in immunocompetent and immunocompromised mice infected with influenza A virus. Biol Pharm Bull. 2010;33(7):1199–1205.
  • Gautam SC, Gao X, Dulchavsky S. Immunomodulation by curcuma.Adv. Exp Med Biol. 2007;595:321–341.
  • Mi HK, Young Byon Y, Ko E J, et al. Immunomodulatory activity of ginsan, a polysaccharide of panax ginseng, on dendritic cells. Korean J Physiol Pharmacol. 2009;13:169–173.
  • Coleman CI, Hebert JH, Reddy P. The effects of Panax ginseng on quality of life. J Clin Pharm Ther. 2003;28:5–15.
  • Dixit Y, Wagle A, Vakil B. Patents in the field of probiotics, prebiotics, synbiotics: a review. J Food Microbiol Saf Hyg. 2016;1:1–13.
  • Dhiman RK, Chawla YK. Herbal medicines for liver diseases. Dig Dis Sci. 2005;50(10):1807–1812.
  • Gestuvo MK, Hung WW. Common dietary supplements for cognitive health. Aging health. 2012;8:89–97.
  • Liu Z, Liang S, Que S, et al. Meta-analysis of adiponectin as a biomarker for the detection of metabolic syndrome. Front Physiol. 2018;9:1238.
  • Larsen JR, Dima L, Correll CU, et al. The pharmacological management of metabolic syndrome. Expert Rev Clin Pharmacol. 2018;11:397–410.
  • Santini A, Novellino E. Nutraceuticals in hypercholesterolemia: an overview. Br J Pharm. 2017;174:1450–1463.
  • Pirillo A, Catapano AL. Berberine, a plant alkaloid with lipid- and glucose-lowering properties: from in vitro evidence to clinical studies. Atherosclerosis. 2015;243:449–461.
  • Banach M, Patti AM, Giglio RV, et al. (ILEP). The role of nutraceuticals in statin intolerant patients. J Am Coll Cardiol. 2018;72:96–118.
  • Yanwen W, Zidichouski JA. Update on the benefits and mechanisms of action of the bioactive vegetal alkaloid berberine on lipid metabolism and homeostasis. Cholesterol. 2018:17. Article ID 7173920. DOI:10.1155/2018/7173920
  • Jing-Wan L, Ke Y, Sui-Cun S, et al. A safer hypoglycemic agent for type 2 diabetes-Berberine organic acid salt. J Funct Foods. 2017;38:399–408.
  • Peng D, Fong A, van Pelt A. The effects of red yeast rice supplementation on cholesterol levels in adults. Am J Nurs. 2017;117:46–54.
  • EFSA. Scientific opinion on the substantiation of health claims related to monacolin K from red yeast rice and maintenance of normal blood LDL cholesterol concentrations (ID 1648, 1700) pursuant to Article 13 (1)of Regulation (EC) No 1924/2006. EFSA J. 2011;9(7):2304.
  • EFSA. Scientific opinion on the safety of monacolins in red yeast rice. EFSA J. 2018;6(8):536.
  • Barrios V, Escobar C, Cicero AFG, et al. A nutraceutical approach (Armolipid Plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia: review of the clinical evidence. Atherosclerosis Suppl. 2017;24:1–15.
  • Ju D H, Seung-Min L, Kim SK, et al. Effect of 1-deoxynojirimycin on cholesterol efflux through ABCA1-LXR alpha pathway in 3T3-L1 adipocytes. J Funct Foods. 2014;7:692–699.
  • Eruygur N, Dural E. Determination of 1-deoxynojirimycin by a developed and validated HPLC-FLD method and assessment of in-vitro antioxidant, α-amylase and α-glucosidase inhibitory activity in Mulberry Varieties from Turkey. Phytomedicine. 2018. DOI:10.1016/j.phymed.2018.09.016
  • Qingpu L, Xuan L, Cunyu L, et al. 1-deoxynojirimycin alleviates liver injury and improves hepatic glucose metabolism in db/db mice. Molecules. 2016;21:279.
  • Hu M, Zeng W, Tomlinson B. Evaluation of a crataegus-based multiherb formula for dyslipidemia: a randomized, double-blind, placebo-controlled clinical trial. Evid Based Complement Alternat Med. 2014;9. Article ID 365742. DOI:10.1155/2014/365742
  • Hayamizu K, Ishii Y, Kaneko I, et al. Effects of garcinia cambogia (Hydroxycitric acid) on visceral fat accumulation: a double-blind, randomized, placebo-controlled trial. Curr Ther Res Clin Exp. 2003;64:551‐567.
  • Alti̇Ner A, Ates A, Gursel FE, et al. Effect of the antiobesity agent Garcinia cambogia extract on serum lipoprotein (a), apolipoproteins a1 and b, and total cholesterol levels in female rats fed atherogenic diet. J Animal Plant Sci. 2012;22:872–877.
  • Peng ML, Han J, Li LL, et al. Metabolomics reveals the mechanism of (−)-hydroxycitric acid promotion of protein synthesis and inhibition of fatty acid synthesis in broiler chickens. Animal. 2018;12:774–783.
  • D’Avino M, Tenore G, Buonomo G, et al. A healthy balance of plasma cholesterol by a novel, smart, nutraceutical product formulated with Annurca campana IGP apple polyphenolic extract. Ital J Aerosp Med. 2016;10:33.
  • Tenore GC, Caruso D, Buonomo G, et al. Annurca (Malus pumila Miller cv. Annurca) apple as a functional food for the contribution to a healthy balance of plasma cholesterol levels: results of a randomized clinical trial. J Sci Food Agric. 2017;97:2107‐2115.
  • Ribas SA, Grando RL, Zago L, et al. Overview of flaxseed patent applications for the reduction of cholesterol levels. Recent Pat Food Nutr Agric. 2016;8:116–123.
  • Cicero AFC, Colletti A, Bajraktari G, et al., on behalf of the International Lipid Expert Panel (ILEP). Lipid lowering nutraceuticals in clinical practice: position paper from an international lipid expert panel. Arch Med Sci. 2017;13:965–1005.
  • Bernal del Nozal J, Ja M, Ibáñez E, et al. Advanced analysis of nutraceuticals. J Pharm Biomed Anal. 2010;55:758–774.
  • Santini A, Novellino E. Nutraceuticals: beyond the diet before the drugs. Curr Bioact Compds. 2014;10:1–12.
  • DeFelice SL. The nutraceutical revolution: its impact on food industry R&D. Trends Food Sci Technol. 1995;6:59–61.
  • Dahiya K. Nutraceuticals and their impact on human health. J Plant Biochem Physiol. 2013;1:e111.
  • Koch A, Sonja S, Suzanne Türpe S, et al. The need for a legal distinction of nutraceuticals. Food Nutr Sci. 2014;5(10):45579.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.